MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC ; volume:46 ; number:2 ; year:2018 ; pages:654-663
Cellular physiology and biochemistry ; 46, Heft 2 (2018), 654-663

Creator: Xie, Wei-Bin
Liang, Li-Hui
Wu, Kai-Ge
Wang, Le-Xing
He, Xin
Song, Cheng
Wang, Yun-Qi
Li, Yun-Hui

DOI: 10.1159/000488634

URN: urn:nbn:de:101:1-201805033403

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Xie, Wei-Bin
Liang, Li-Hui
Wu, Kai-Ge
Wang, Le-Xing
He, Xin
Song, Cheng
Wang, Yun-Qi
Li, Yun-Hui

Other Objects (12)

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

TIPE2 knockdown exacerbates isoflurane-induced postoperative cognitive impairment in mice by inducing activation of STAT3 and NF-κB signaling pathways

The State Advances, the People Retreat

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response

rs822336 binding to C/EBPβ and NFIC modulates induction of PD-L1 expression and predicts anti-PD-1/PD-L1 therapy in advanced NSCLC

Expression and clinical significance of miR-204 in patients with hypertensive disorder complicating pregnancy

High miR-200a-3p expression has high diagnostic values for hypertensive disorders complicating pregnancy and predicts adverse pregnancy outcomes

Rapid response of Nelson’s syndrome to pasireotide in radiotherapy-naive patient

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors

Continuous targeted kinase inhibitors treatment induces upregulation of PD-L1 in resistant NSCLC

Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients

Related objects

Reset password